Drug intelligence / Profile preview

Obefit

Development stage: Unknown
Lead developer: Ankh Pharmaceuticals
Administration: Oral

Overview

Obefit is a branded herbal and Ayurvedic supplement developed by Ankh Pharmaceuticals, specifically formulated for weight management and obesity support. It is part of a broader line of 13 consumer wellness products that include treatments for diabetes support, digestion, and joint pain. As an herbal consumer product, Obefit is marketed for general wellness rather than as a clinical drug candidate with specific molecular targets or defined clinical trial phases. It is typically administered orally to support metabolic health.

Brand names: Obefit
Other names: Obefit

Beyond the preview

Go deeper on Obefit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Obefit.

Explore the full profile